Close

Monoclonal Zebrafish Antibody Discovery Introduction

Overview Application Scenarios Workflow Platforms Our Core Advantages FAQ

Why Zebrafish? The 450-Million-Year Answer

Zebrafish (Danio rerio) shares 87% genomic homology with humans. Its adaptive immune system such as IgH, TCR, MHC is structurally and functionally conserved, enabling V(D)J recombination, affinity maturation, and full antibody responses.

Traditional mouse/rabbit approaches fail because of their close evolutionary relationship to humans (~96 million years), causing immune tolerance for proteins with >85% homology. Moreover, multi‑spanning membrane proteins lose native conformation during recombinant expression, hiding critical epitopes.

Fig.1 Zebrafish. (Creative Biolabs AI)

Zebrafish mAb breaks three major barriers:

Immunogenicity

450 million years of divergence makes human proteins strongly immunogenic in zebrafish, breaking self‑tolerance.

Conformational display

Live‑animal immunization preserves native membrane orientation and post‑translational modifications, ideal for GPCRs/ion channels.

Minimal antigen requirement

Only <50 μg antigen needed, enabling difficult‑to‑express targets.

Calculate your target difficulty rating

Unmatched Core Advantages

Fig.2 Zebrafish One. (Creative Biolabs AI)

Exceptional Diversity

Thousands of unique clones are readily obtainable with large library capacity, delivering far broader coverage of CDR space than hybridoma technology.

Fig.3 Coverage Rate. (Creative Biolabs AI)

Comprehensive Epitope Coverage

Up to 70% improvement in accessing hidden ECD epitopes recognizing conserved conformational epitopes missed by rodents.

Fig.4 Lead Time. (Creative Biolabs AI)

Accelerated Timeline

Immunization-to-positive-clone screening is completed within weeks rather than months, drastically accelerating target validation.

Fig.5 Native Structure. (Creative Biolabs AI)

Native Conformation Retention

Live‑animal immunization preserves membrane localization and PTMs, yielding antibodies with true biological relevance.

Book a 1‑on‑1 with our Technical Director

Zebrafish mAb Application Scenarios

Empowering the entire value chain from drug R&D to diagnostic tools.

  • Therapeutic Antibody Discovery

Rapidly generate high‑affinity lead antibodies against hard‑to‑drug targets (GPCRs, ion channels) for functional validation, in vivo efficacy studies, and subsequent humanization. Zebrafish‑derived CDR sequences offer differentiated IP space for better FTO positioning.

Fig.6 Antibody Discovery. (Creative Biolabs AI)

Fig.7 Diagnostic Reagents. (Creative Biolabs AI)

  • Diagnostic Reagent Development

Provide sequence‑defined, batch‑to‑batch consistent recombinant monoclonal antibodies with strict epitope specificity and affinity fully compliant with IVD regulatory requirements.

  • Basic Research & Translational Medicine

Deliver high‑specificity tool antibodies for signaling pathway dissection, protein‑protein interaction studies, cell typing, and biomarker discovery finally overcoming the "can't find a good antibody" bottleneck.

Fig.8 Basic Research. (Creative Biolabs AI)

Learn More About Zebrafish Monoclonal Antibody Applications

Zebrafish mAb Workflow

Antigen immunization & titer monitoring

<50 μg antigen and proprietary adjuvant, live‑animal immunization, preserving membrane protein conformation.

Immune library generation

RNA from spleen/kidney, V‑gene amplification, phage display library (≥108 independent clones).

Multi‑modal panning

solid‑phase, liquid‑phase, or cell‑based panning to efficiently enrich clones against complex conformational epitopes.

Recombinant expression & functional validation

scFv/Fab/IgG formats, ELISA, SPR, FACS multi‑dimensional verification.

Curious about the antigen-to-lead development timeline? Get your custom project roadmap

Full-Service Platform

Equipped with versatile technical platforms, Creative Biolabs offers tailored services aligned with target features and research aims to help you obtain zebrafish mAbs.

All outstanding research projects stem from suitable technical systems. Creative Biolabs support you in platform selection and realize your experimental goals. Consult our technical team for professional decision support

Advantages of Creative Biolabs

Possessing decades of in-depth experience in antibody R&D, Creative Biolabs stands as a trusted collaborative partner for numerous research institutions and biotech pharmaceutical companies, supported by robust technical strengths and a large portfolio of successfully delivered projects.

Diversified multi-species antibody development platform

Creative Biolabs has completed antibody screening and development services targeting mice, rabbits, alpacas, swine, humans and many other species, catering to varied research and preclinical study requirements.

End-to-end one-stop full lifecycle technical solutions

Creative Biolabs offer integrated full-range services from antigen design down to antibody functional validation, saving clients the complicated coordination work of engaging different service vendors individually.

Fast turnaround timeline coupled with rigorous quality management protocols

Standardized SOPs and comprehensive quality control systems ensure complete traceability for all experimental records and raw data.

Elite and highly experienced technical R&D team

Creative Biolabs' core technical team is composed of doctorate-level scientists with extensive project track records, who can furnish thorough, specialized technical consultation at every stage of your project.

Creative Biolabs consistently drives industrial translation with in-depth technology, safeguarding your entire drug development pipeline at every stage. Safeguarding your pipeline →

Technical FAQ

  1. What is the structural difference between zebrafish and human/mouse antibodies?

    Zebrafish antibodies (IgH, IgL) differ in constant regions, but their variable domains (CDRs) share highly conserved conformational diversity and affinity maturation machinery. This divergence allows them to recognize conserved human epitopes that rodents cannot, and zebrafish V‑regions humanize with high efficiency.

  2. What is the minimum antigen requirement for Zebrafish mAb?

    Only <50 μg of purified protein or 1×107 overexpressing cells are needed to initiate immunization. For difficult‑to‑express membrane proteins, Creative Biolabs support DNA-based or cell‑based immunization to minimize antigen preparation hurdles.

  3. Can you directly generate fully human antibodies?

    Yes. In addition to zebrafish‑derived chimeric antibodies, we offer humanization services (CDR grafting + back‑mutation optimization). Creative Biolabs also support generating fully human antibodies via transgenic mouse alternatives using zebrafish immune repertoires, the path is tailored to your IP and development strategy.

Get Your Quote Instantly. Custom Zebrafish Monoclonal Antibody Discovery Solutions


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us